First Hawaiian Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

First Hawaiian Bank’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,700	Closed	-$966K	–	176
2024 Q4	$966K	Buy	14,700 +200	+1%	+$13.4K	0.03%	422
2024 Q3	$1.02M	Sell	14,500 -1,000	-6%	-$83.6K	0.03%	418
2024 Q2	$1.28M	Sell	15,500 -400	-3%	-$33.3K	0.04%	319
2024 Q1	$1.39M	Sell	15,900 -32	-0.2%	-$2.87K	0.04%	316
2023 Q4	$1.54M	Buy	15,932 +432	+3%	+$38.2K	0.05%	292
2023 Q3	$1.37M	Hold	15,500	–	–	0.05%	298
2023 Q2	$1.34M	Hold	15,500	–	–	0.04%	307
2023 Q1	$1.51M	Hold	15,500	–	–	0.05%	275
2022 Q4	$1.6M	Hold	15,500	–	–	0.06%	254
2022 Q3	$1.31M	Hold	15,500	–	–	0.05%	273
2022 Q2	$1.28M	Hold	15,500	–	–	0.05%	289
2022 Q1	$1.2M	Hold	15,500	–	–	0.04%	328
2021 Q4	$1.37M	Buy	+15,500	New	+$1.28M	0.04%	315
2019 Q3	–	Sell	-6,300	Closed	-$540K	–	820
2019 Q2	$540K	Sell	6,300 -2,635	-29%	-$225K	0.03%	428
2019 Q1	$794K	Buy	8,935 +200	+2%	+$18.5K	0.04%	306
2018 Q4	$744K	Sell	8,735 -100	-1%	-$9.51K	0.04%	295
2018 Q3	$857K	Buy	+8,835	New	+$882K	0.04%	307

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Hawaiian Bank's BMRN Position: Q1 2025 in Review

First Hawaiian Bank sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2025, closing a stake of 14,700 shares — an estimated $966K sold.

First Hawaiian Bank first reported a position in BMRN in Q3 2018 and held it in 17 quarters. The position peaked at $1.6M in Q4 2022. 584 funds tracked by Wall St. Rank hold BMRN as of Q1 2025.

First Hawaiian Bank reported no remaining BioMarin Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
First Hawaiian Bank sold 14,700 BioMarin Pharmaceuticals shares in Q1 2025, an estimated $966K.
First Hawaiian Bank first reported a position in BioMarin Pharmaceuticals in Q3 2018 and held it in 17 quarters.
First Hawaiian Bank's BioMarin Pharmaceuticals position peaked at $1.6M in Q4 2022.
584 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.